Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy

被引：0
|
作者：
Bailey, C. J. [1 ]
Gross, J. L. [2 ]
Yadav, M. [3 ]
Iqbal, N. [4 ]
Mansfield, T. A. [4 ]
List, J. F. [4 ]
机构：
[1] Aston Univ, Birmingham B4 7ET, W Midlands, England
[2] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[3] Bristol Myers Squibb, Bombay, Maharashtra, India
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
146
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
    DeFronzo, Ralph A.
    Hissa, Miguel N.
    Garber, Alan J.
    Gross, Jorge Luiz
    Duan, Raina Yuyan
    Ravichandran, Shoba
    Chen, Roland S.
    DIABETES CARE, 2009, 32 (09) : 1649 - 1655
  • [2] Efficacy and Safety of Linagliptin in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy
    Taskinen, Marja-Riitta
    Rosenstock, Julio
    Tamminen, Ilkka
    Kubiak, Rene
    Patel, Sanjay
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    DIABETES, 2010, 59 : A158 - A158
  • [3] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
    Pavlicek, V.
    DIABETOLOGE, 2011, 7 (01): : 37 - 38
  • [4] Efficacy and Tolerability of Vildagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy
    Goodman, M.
    Thurston, H.
    Penman, J.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (05) : 368 - 373
  • [5] A phase 3 trial to evaluate the efficacy and safety of chiglitazar added to metformin in Chinese patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Gao, L.
    Ji, L.
    Dong, X.
    Cheng, Z.
    Zhang, X.
    Sun, W.
    Ma, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S359 - S360
  • [6] Efficacy of glyburide/metformin tablets versus metformin plus rosiglitazone in patients with Type 2 diabetes inadequately controlled with metformin monotherapy.
    Mohideen, P
    Klein, E
    Bruce, S
    DIABETOLOGIA, 2002, 45 : A242 - A242
  • [7] Efficacy and safety of saxagliptin plus metformin versus acarbose plus metformin in type 2 diabetes patients inadequately controlled with metformin monotherapy
    Du, J.
    Liang, L.
    Fang, H.
    Xu, F.
    Li, W.
    Shen, L.
    Mu, Y.
    DIABETOLOGIA, 2016, 59 : S372 - S372
  • [8] Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Garber, A
    Klein, E
    Bruce, S
    Sankoh, S
    Mohideen, P
    DIABETES OBESITY & METABOLISM, 2006, 8 (02): : 156 - 163
  • [9] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
    Bailey, C. J.
    Gross, J. L.
    Bastone, L.
    Bastien, A.
    List, J. F.
    DIABETOLOGIA, 2009, 52 : S76 - S76
  • [10] Efficacy and safety of gemigliptin compared with sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone
    Rhee, E. J.
    Min, K. W.
    Jang, H. C.
    Chung, C. H.
    Nam-Goong, I. S.
    Bae, H. Y.
    Lee, M. K.
    Baik, S. H.
    Shivane, V. K.
    Sosale, A. R.
    Dharmalingam, M.
    Gandhi, P.
    Gupta, S. K.
    Kim, J. A.
    Kim, S. W.
    DIABETOLOGIA, 2012, 55 : S352 - S352
12345